`
`
`Trials@uspto.gov
`571-272-7822
`
`
`Paper No. 95
`Entered: April 11, 2016
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`____________
`
`ACCORD HEALTHCARE INC., USA, ACCORD HEALTHCARE, INC.,
`INTAS PHARMACEUTICALS LTD., AMNEAL PHARMACEUTICALS
`LLC, AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`AMNEAL PHARMACEUTICALS CO. INDIA PVT. LTD., APOTEX
`CORP., APOTEX INC., DR. REDDY’S LABORATORIES, LTD., DR.
`REDDY’S LABORATORIES, INC., GLENMARK GENERICS INC.,
`USA, GLENMARK GENERICS LTD., GLENMARK
`PHARMACEUTICALS LTD., PANACEA BIOTEC LTD., SUN PHARMA
`GLOBAL FZE, TEVA PHARMACEUTICALS USA, INC., ZYDUS
`PHARMACEUTICALS USA, INC., CADILA HEALTHCARE LTD,
`LUPIN LTD., AND LUPIN PHARMACEUTICALS, INC.
`Petitioners,
`
`v.
`
`DAIICHI SANKYO COMPANY, LIMITED AND
`UBE INDUSTRIES, LTD.,
`Patent Owners.
`____________
`
`Case IPR2015-00864 (Patent 8,404,703 B2)1, 2
`Case IPR2015-00865 (Patent 8,569,325 B2)3
`____________
`
`Before ERICA A. FRANKLIN, TINA E. HULSE, and
`CHRISTOPHER G. PAULRAJ, Administrative Patent Judges.
`
`HULSE, Administrative Patent Judge.
`
`
`1 This Order addresses issues that are common to each case.
`2 Case IPR2015-01882 has been joined with Case IPR2015-00864.
`3 Case IPR2015-01881 has been joined with Case IPR2015-00865.
`
`
`
`IPR2015-00864 (8,404,703 B2)
`IPR2015-00865 (8,569,325 B2)
`
`
`
`
`
`ORDER
`Trial Hearing
`37 C.F.R. § 42.70
`
`
`
`
`
`
`Pursuant to our prior orders, oral argument is scheduled to be held in
`both IPR2015-00864 and IPR2015-00865 on May 2, 2016, if requested by
`the parties. IPR2015-00864, Paper 37; IPR2015-00865, Paper 29.
`Petitioners and Patent Owner have requested oral argument in both cases.
`IPR2015-00864, Papers 87, 88; IPR2015-00865, Paper 87, 88. The requests
`are granted.
`The oral argument will commence at 2:00 PM Eastern Time, on
`Monday, May 2, 2016, in Hearing Room A on the ninth floor of Madison
`Building East, 600 Dulany Street, Alexandria, Virginia 22314.
`Each party will have 45 minutes to present arguments and may
`determine for itself how to divide the time between the two cases.
`Petitioners bear the ultimate burden of proof that Patent Owner’s patent
`claims at issue are unpatentable. Therefore, at oral argument, Petitioners
`will proceed first to present its case with respect to the challenged patent
`claims and the grounds on which the Board instituted trial.4 Petitioners may
`reserve some of its argument time for rebuttal. Patent Owner will then
`respond to Petitioners’ initial presentation. Finally, Petitioners may use the
`time it has reserved to reply to Patent Owner’s presentation.
`
`
`4 As per our order joining cases IPR2015-01881 and IPR2015-01882 with
`these proceedings, we expect Petitioners to present a single argument on
`behalf of all Petitioners. See IPR2015-01881, Paper 11; IPR2015-01882,
`Paper 11.
`
`2
`
`
`
`
`IPR2015-00864 (8,404,703 B2)
`IPR2015-00865 (8,569,325 B2)
`
`
`
`
`
`The Board will provide a court reporter for the oral argument, and the
`reporter’s transcript will constitute the official record of the oral argument.
`The hearing transcript will be entered in the record of this proceeding. The
`oral argument will be open to the public for in-person attendance, which will
`be accommodated on a first-come, first-served basis.
`The parties shall serve any demonstrative exhibits on opposing
`counsel at least five business days before the hearing. The parties shall also
`provide a courtesy copy of any demonstrative exhibits to the Board no later
`than three business days before the hearing by emailing them to
`Trials@uspto.gov. Notwithstanding 37 C.F.R. § 42.70(b), the parties shall
`not file any demonstrative exhibits in these proceedings without prior
`authorization from the Board.
`The parties are directed to St. Jude Medical, Cardiology Division, Inc.
`v. The Board of Regents of the University of Michigan, IPR2013-00041
`(PTAB Jan. 27, 2014) (Paper 65), for guidance regarding the appropriate
`content of demonstrative exhibits. The parties shall confer with each other
`regarding any objections to demonstrative exhibits. For any issue that
`cannot be resolved after conferring, the parties may each file a one-page list
`of objections at least three business days before the hearing. The list should
`identify with particularity which demonstrative exhibits are subject to
`objection and include a short statement of the reason for each objection. No
`argument or further explanation is permitted.
`The Board will consider the objections and schedule a telephone
`conference if deemed necessary. Otherwise, the Board will reserve ruling on
`
`3
`
`
`
`
`
`
`IPR2015-00864 (8,404,703 B2)
`IPR2015-00865 (8,569,325 B2)
`
`
`the objections until after the oral argument. Any objection to demonstrative
`exhibits that is not timely presented will be considered waived.
`The parties are advised that at least one member of the panel will be
`attending the hearing from a remote location. The parties are reminded that
`the presenter must identify clearly and specifically each demonstrative
`exhibit (e.g., by slide or screen number) referenced during the hearing to
`ensure the clarity and accuracy of the reporter’s transcript and the ability of
`the judge participating remotely to follow the presenter’s arguments.
`The Board expects lead counsel for each party to be present at oral
`hearing, although any backup counsel may make the actual presentation, in
`whole or in part. If lead counsel for either party will not be in attendance at
`oral hearing, the Board should be notified via a joint telephone conference
`call no later than two business days before the oral hearing to discuss the
`matter.
`The parties may request the use of audio-visual equipment during the
`oral hearing. Formal requests are to be made five business days in advance
`of the hearing date and should be sent to Trials@uspto.gov. If the request is
`not timely, the equipment may not be available on the day of the hearing.
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`
`
`
`IPR2015-00864 (8,404,703 B2)
`IPR2015-00865 (8,569,325 B2)
`
`PETITIONERS:
`Douglass Hochstetler
`KELLEY DRYE & WARREN LLP
`dhochstetler@kelleydrye.com
`
`Samuel Park
`George Lombardi
`Maureen Rurka
`Charles Klein
`WINSTON & STRAWN LLP
`Prasugrel-IPR@winston.com
`GLombardi@winston.com
`MRurka@winston.com
`CKlein@winston.com
`
`Patrick Gallagher
`DUANE MORRIS LLP
`pcgallagher@duanemorris.com
`
`William Mentlik
`LERNER, DAVID, LITTENBERG,
`Krumholz & Mentlik, LLP
`WMentlik@ldlkm.com
`
`Azadeh Kokabi
`SUGHRUE MION PLLC
`akokabi@sughrue.com
`
`Steve Moore
`John Winterle
`Hans-Peter Hoffman
`Alan Gardner
`WITHERS BERGMAN LLP
`steven.moore@withersworldwide.com
`john.winterle@withersworldwide.com
`hans-peter.hoffmann@withersworldwide.com
`alan.gardner@withersworldwide.com
`
`
`5
`
`
`
`
`
`
`
`
`IPR2015-00864 (8,404,703 B2)
`IPR2015-00865 (8,569,325 B2)
`
`PATENT OWNER:
`Dov Grossman
`David Krinsky
`Adam Perlman
`WILLIAMS & CONNOLLY LLP
`dgrossman@wc.com
`dkrinsky@wc.com
`aperlman@wc.com
`
`
`
`6
`
`
`